O'Reilly Automotive vs Abridge
Side-by-side comparison of AI visibility scores, market position, and capabilities
Springfield MO auto parts retail (NASDAQ: ORLY) at record $16.71B FY2024 sales (+6%); 32 consecutive years comp growth, 6,200+ stores, professional + DIY dual-market competing with AutoZone and Advance Auto.
About
O'Reilly Automotive, Inc. is a Springfield, Missouri-based specialty retailer and supplier of automotive aftermarket parts, tools, supplies, equipment, and accessories — publicly traded on NASDAQ (NASDAQ: ORLY) as an S&P 500 Consumer Discretionary component — operating approximately 6,200 stores across 48 states, Puerto Rico, Canada, and Mexico, serving both do-it-yourself (DIY) consumers who repair their own vehicles and professional service providers (DIFM, Do-It-For-Me — auto repair shops, body shops, dealerships) through approximately 89,000 team members. In fiscal year 2024, O'Reilly reported record full-year sales of $16.71 billion (+6% year-over-year) and net income of $2.39 billion (+2%), marking 32 consecutive years of comparable store sales growth — an unbroken streak through multiple recessions, pandemic disruptions, and consumer spending cycles. Fourth quarter comparable store sales grew 4.4% driven by solid growth in both professional and DIY segments, with 198 net new stores opened during 2024. CEO Brad Beckham, who took over in March 2023 from Greg Johnson, continues the operational discipline that has made O'Reilly the most consistently profitable auto parts retailer in the US — maintaining the dual-market strategy that simultaneously serves professional mechanics who need parts immediately (same-day delivery from O'Reilly's 200+ distribution centers to the repair shop) and weekend DIY customers who replace their own brakes, oil filters, and batteries with O'Reilly team member assistance.
Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.
About
Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.